Probing Guanidino Pendant or Bridged Groups in Cyclic Antimicrobial Peptides Derived from Temporin L: A Strategy to Improve Efficacy against Gram-Negative Bacteria
Journal of Medicinal Chemistry · 11.12.2025 · 68 (23) · 25038-25060
DOI: 10.1021/acs.jmedchem.5c01984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 01.12.2025. Verfasst von Rosa Bellavita und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Naples Federico II, via Domenico Montesano 49, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Gram-Negative Bacteria, Anti-Bacterial Agents, Antimicrobial Peptides, Peptides, Cyclic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza Universit? di Roma, Ministero dell'Universit? e della Ricerca.
Abstract (Originalsprache)
The rise of antibiotic resistance underscores the urgent need for new antimicrobial agents. Antimicrobial peptides (AMPs), such as temporins, offer broad-spectrum activity through unique mechanisms but are often limited by cytotoxicity and poor stability. To improve the Gram-negative activity-to-toxicity ratio, we designed a focused library of cyclic Temporin L (TL) analogues bearing an additional positively charged guanidino group, introduced either as a side-chain pendant or as a bridged functionality. While guanidino modifications have been studied in side-chain peptide contexts, this represents the first application of guanidino-based bridging in AMP design. Among the synthesized compounds, four (e.g., 2, 6, 7 and 12) were selected based on their combined antimicrobial potency and low cytotoxicity toward human keratinocytes, emerging as the most structurally representative candidates of the introduced modifications. Further characterization provided an integrated view of their biological properties, highlighting guanidino-based cyclic temporins as attractive agents and a framework for developing next-generation therapeutics against resistant and biofilm-associated infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Naples Federico II, via Domenico Montesano 49, 80131 Naples, Italy.
- Department of Biochemical Sciences, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, p.le Aldo Moro 5, Rome 00185, Italy.
- DiSTABiF, University of Campania Luigi Vanvitelli, via Vivaldi 43, 81100 Caserta, Italy.
ORCID-Profile: Rosa Bellavita, Ida Boccino, Sara Palladino, Vincenzo Mazzarella, Salvatore Di Maro, Stefania Galdiero, Bruno Casciaro, Paolo Grieco, Maria Luisa Mangoni, Francesco Merlino
Förderung
- Sapienza Universit? di Roma
- Ministero dell'Universit? e della Ricerca
Zitieren
APA
Bellavita, R., Boccino, I., Loffredo, M. R., Palladino, S., Cappiello, F., Vetrano, C., Tortellini, E., Mazzarella, V., Di Maro, S., Galdiero, S., Casciaro, B., Grieco, P., Mangoni, M. L., & Merlino, F. (2025). Probing Guanidino Pendant or Bridged Groups in Cyclic Antimicrobial Peptides Derived from Temporin L: A Strategy to Improve Efficacy against Gram-Negative Bacteria. Journal of Medicinal Chemistry, 68(23), 25038-25060. https://doi.org/10.1021/acs.jmedchem.5c01984
Vancouver
Bellavita R, Boccino I, Loffredo MR, Palladino S, Cappiello F, Vetrano C, et al. Probing Guanidino Pendant or Bridged Groups in Cyclic Antimicrobial Peptides Derived from Temporin L: A Strategy to Improve Efficacy against Gram-Negative Bacteria. Journal of Medicinal Chemistry. 2025;68(23):25038-25060. doi:10.1021/acs.jmedchem.5c01984
BibTeX
@article{Bellavita2025,
author = {Bellavita, Rosa and Boccino, Ida and Loffredo, Maria Rosa and Palladino, Sara and Cappiello, Floriana and Vetrano, Carlo and Tortellini, Eeva and Mazzarella, Vincenzo and Di Maro, Salvatore and Galdiero, Stefania and Casciaro, Bruno and Grieco, Paolo and Mangoni, Maria Luisa and Merlino, Francesco},
title = {Probing Guanidino Pendant or Bridged Groups in Cyclic Antimicrobial Peptides Derived from Temporin L: A Strategy to Improve Efficacy against Gram-Negative Bacteria},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {23},
pages = {25038--25060},
doi = {10.1021/acs.jmedchem.5c01984}
}
EUVIMED